KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $6.4 million.

  • Chemed's Other Working Capital Changes rose 1119.25% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.6 million, marking a year-over-year decrease of 26743.79%. This contributed to the annual value of $25.6 million for FY2024, which is 15714.43% up from last year.
  • According to the latest figures from Q3 2025, Chemed's Other Working Capital Changes is $6.4 million, which was up 1119.25% from -$52.9 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Other Working Capital Changes ranged from a high of $46.1 million in Q3 2022 and a low of -$52.9 million during Q2 2025
  • Its 5-year average for Other Working Capital Changes is $2.6 million, with a median of $3.5 million in 2021.
  • As far as peak fluctuations go, Chemed's Other Working Capital Changes soared by 122775.7% in 2022, and later plummeted by 179301.73% in 2025.
  • Chemed's Other Working Capital Changes (Quarter) stood at -$3.3 million in 2021, then soared by 203.04% to $3.4 million in 2022, then tumbled by 60.36% to $1.3 million in 2023, then soared by 237.59% to $4.5 million in 2024, then surged by 42.05% to $6.4 million in 2025.
  • Its Other Working Capital Changes stands at $6.4 million for Q3 2025, versus -$52.9 million for Q2 2025 and $4.4 million for Q1 2025.